nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.555	1	CbGbCtD
Trisalicylate-choline—Intoxication—Aminophylline—chronic obstructive pulmonary disease	0.0235	0.0637	CcSEcCtD
Trisalicylate-choline—Poisoning—Aminophylline—chronic obstructive pulmonary disease	0.0235	0.0637	CcSEcCtD
Trisalicylate-choline—Epigastric pain—Aminophylline—chronic obstructive pulmonary disease	0.0131	0.0355	CcSEcCtD
Trisalicylate-choline—Epigastric pain—Salbutamol—chronic obstructive pulmonary disease	0.00943	0.0255	CcSEcCtD
Trisalicylate-choline—Heartburn—Aminophylline—chronic obstructive pulmonary disease	0.00922	0.0249	CcSEcCtD
Trisalicylate-choline—Pulmonary function test decreased—Aminophylline—chronic obstructive pulmonary disease	0.00842	0.0228	CcSEcCtD
Trisalicylate-choline—Respiratory depression—Aminophylline—chronic obstructive pulmonary disease	0.00842	0.0228	CcSEcCtD
Trisalicylate-choline—Heartburn—Salbutamol—chronic obstructive pulmonary disease	0.00662	0.0179	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Aminophylline—chronic obstructive pulmonary disease	0.00606	0.0164	CcSEcCtD
Trisalicylate-choline—PTGS1—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.00584	0.0948	CbGpPWpGaD
Trisalicylate-choline—Lightheadedness—Aminophylline—chronic obstructive pulmonary disease	0.00567	0.0154	CcSEcCtD
Trisalicylate-choline—PTGS2—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.00464	0.0753	CbGpPWpGaD
Trisalicylate-choline—Abdominal pain upper—Aminophylline—chronic obstructive pulmonary disease	0.0042	0.0114	CcSEcCtD
Trisalicylate-choline—Lightheadedness—Salbutamol—chronic obstructive pulmonary disease	0.00408	0.011	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.00407	0.011	CcSEcCtD
Trisalicylate-choline—PTGS2—leg—chronic obstructive pulmonary disease	0.00365	0.311	CbGeAlD
Trisalicylate-choline—Stinging—Prednisolone—chronic obstructive pulmonary disease	0.00323	0.00873	CcSEcCtD
Trisalicylate-choline—Epistaxis—Tiotropium—chronic obstructive pulmonary disease	0.00316	0.00854	CcSEcCtD
Trisalicylate-choline—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.00303	0.00819	CcSEcCtD
Trisalicylate-choline—Asthma—Formoterol—chronic obstructive pulmonary disease	0.00303	0.00819	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Salbutamol—chronic obstructive pulmonary disease	0.00302	0.00817	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00299	0.00808	CcSEcCtD
Trisalicylate-choline—Asthma—Montelukast—chronic obstructive pulmonary disease	0.00297	0.00802	CcSEcCtD
Trisalicylate-choline—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00296	0.008	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00295	0.00798	CcSEcCtD
Trisalicylate-choline—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.0029	0.00785	CcSEcCtD
Trisalicylate-choline—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.00286	0.00774	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.0028	0.00756	CcSEcCtD
Trisalicylate-choline—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.0027	0.00729	CcSEcCtD
Trisalicylate-choline—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00264	0.00715	CcSEcCtD
Trisalicylate-choline—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00255	0.0069	CcSEcCtD
Trisalicylate-choline—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.00249	0.00675	CcSEcCtD
Trisalicylate-choline—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.00244	0.00661	CcSEcCtD
Trisalicylate-choline—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.0024	0.00651	CcSEcCtD
Trisalicylate-choline—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00237	0.00642	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Prednisolone—chronic obstructive pulmonary disease	0.00236	0.00639	CcSEcCtD
Trisalicylate-choline—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.00236	0.00639	CcSEcCtD
Trisalicylate-choline—Magnesium salicylate—ALB—chronic obstructive pulmonary disease	0.00234	1	CrCbGaD
Trisalicylate-choline—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00232	0.00628	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00224	0.00607	CcSEcCtD
Trisalicylate-choline—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00224	0.00607	CcSEcCtD
Trisalicylate-choline—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00223	0.00602	CcSEcCtD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—HMOX1—chronic obstructive pulmonary disease	0.00218	0.0354	CbGpPWpGaD
Trisalicylate-choline—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00216	0.00584	CcSEcCtD
Trisalicylate-choline—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00216	0.00584	CcSEcCtD
Trisalicylate-choline—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00214	0.00579	CcSEcCtD
Trisalicylate-choline—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00214	0.00578	CcSEcCtD
Trisalicylate-choline—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00213	0.00577	CcSEcCtD
Trisalicylate-choline—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00213	0.00577	CcSEcCtD
Trisalicylate-choline—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00213	0.00575	CcSEcCtD
Trisalicylate-choline—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00212	0.00575	CcSEcCtD
Trisalicylate-choline—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00211	0.00572	CcSEcCtD
Trisalicylate-choline—Shock—Tiotropium—chronic obstructive pulmonary disease	0.0021	0.00568	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00207	0.00559	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00207	0.00559	CcSEcCtD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—ELANE—chronic obstructive pulmonary disease	0.00203	0.033	CbGpPWpGaD
Trisalicylate-choline—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00202	0.00545	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00199	0.00539	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00197	0.00532	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00195	0.00528	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00188	0.00508	CcSEcCtD
Trisalicylate-choline—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00182	0.00494	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.00181	0.00491	CcSEcCtD
Trisalicylate-choline—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.0018	0.00486	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.00174	0.0047	CcSEcCtD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—HMOX1—chronic obstructive pulmonary disease	0.00173	0.0281	CbGpPWpGaD
Trisalicylate-choline—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00172	0.00466	CcSEcCtD
Trisalicylate-choline—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00172	0.00466	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.00172	0.00465	CcSEcCtD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	0.00171	0.0277	CbGpPWpGaD
Trisalicylate-choline—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.0017	0.00459	CcSEcCtD
Trisalicylate-choline—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00169	0.00456	CcSEcCtD
Trisalicylate-choline—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00163	0.0044	CcSEcCtD
Trisalicylate-choline—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00161	0.00435	CcSEcCtD
Trisalicylate-choline—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00161	0.00435	CcSEcCtD
Trisalicylate-choline—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.0016	0.00433	CcSEcCtD
Trisalicylate-choline—Shock—Salbutamol—chronic obstructive pulmonary disease	0.0016	0.00433	CcSEcCtD
Trisalicylate-choline—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—chronic obstructive pulmonary disease	0.00157	0.0255	CbGpPWpGaD
Trisalicylate-choline—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00157	0.00425	CcSEcCtD
Trisalicylate-choline—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00155	0.00419	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00155	0.00419	CcSEcCtD
Trisalicylate-choline—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00153	0.00414	CcSEcCtD
Trisalicylate-choline—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00153	0.00414	CcSEcCtD
Trisalicylate-choline—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00152	0.00411	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00152	0.0041	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00152	0.0041	CcSEcCtD
Trisalicylate-choline—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00151	0.00408	CcSEcCtD
Trisalicylate-choline—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.0015	0.00406	CcSEcCtD
Trisalicylate-choline—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.0015	0.00405	CcSEcCtD
Trisalicylate-choline—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.00149	0.00404	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00148	0.00402	CcSEcCtD
Trisalicylate-choline—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00147	0.00398	CcSEcCtD
Trisalicylate-choline—Pain—Formoterol—chronic obstructive pulmonary disease	0.00147	0.00398	CcSEcCtD
Trisalicylate-choline—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00147	0.00398	CcSEcCtD
Trisalicylate-choline—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00147	0.00398	CcSEcCtD
Trisalicylate-choline—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00391	CcSEcCtD
Trisalicylate-choline—Pain—Montelukast—chronic obstructive pulmonary disease	0.00144	0.0039	CcSEcCtD
Trisalicylate-choline—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00144	0.00389	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00387	CcSEcCtD
Trisalicylate-choline—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00143	0.00386	CcSEcCtD
Trisalicylate-choline—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00143	0.00386	CcSEcCtD
Trisalicylate-choline—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.00142	0.0231	CbGpPWpGaD
Trisalicylate-choline—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00142	0.00384	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00142	0.00384	CcSEcCtD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.00142	0.023	CbGpPWpGaD
Trisalicylate-choline—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00142	0.00383	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00382	CcSEcCtD
Trisalicylate-choline—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00141	0.00382	CcSEcCtD
Trisalicylate-choline—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.00141	0.00381	CcSEcCtD
Trisalicylate-choline—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00139	0.00376	CcSEcCtD
Trisalicylate-choline—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00139	0.00376	CcSEcCtD
Trisalicylate-choline—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00137	0.0037	CcSEcCtD
Trisalicylate-choline—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.0037	CcSEcCtD
Trisalicylate-choline—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00136	0.00367	CcSEcCtD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	0.00135	0.022	CbGpPWpGaD
Trisalicylate-choline—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00135	0.00364	CcSEcCtD
Trisalicylate-choline—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00134	0.00364	CcSEcCtD
Trisalicylate-choline—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00134	0.00364	CcSEcCtD
Trisalicylate-choline—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00134	0.00363	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00134	0.00363	CcSEcCtD
Trisalicylate-choline—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00134	0.00362	CcSEcCtD
Trisalicylate-choline—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00349	CcSEcCtD
Trisalicylate-choline—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00127	0.00343	CcSEcCtD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.00123	0.02	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00122	0.0198	CbGpPWpGaD
Trisalicylate-choline—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00122	0.0033	CcSEcCtD
Trisalicylate-choline—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.0033	CcSEcCtD
Trisalicylate-choline—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00323	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00118	0.00319	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00118	0.00319	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00115	0.00312	CcSEcCtD
Trisalicylate-choline—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00311	CcSEcCtD
Trisalicylate-choline—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00114	0.00309	CcSEcCtD
Trisalicylate-choline—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00308	CcSEcCtD
Trisalicylate-choline—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00308	CcSEcCtD
Trisalicylate-choline—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.00113	0.0184	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.00113	0.0183	CbGpPWpGaD
Trisalicylate-choline—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00112	0.00302	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00301	CcSEcCtD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.00111	0.018	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MMP12—chronic obstructive pulmonary disease	0.0011	0.0179	CbGpPWpGaD
Trisalicylate-choline—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00296	CcSEcCtD
Trisalicylate-choline—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00296	CcSEcCtD
Trisalicylate-choline—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00294	CcSEcCtD
Trisalicylate-choline—Rash—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00294	CcSEcCtD
Trisalicylate-choline—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00293	CcSEcCtD
Trisalicylate-choline—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00293	CcSEcCtD
Trisalicylate-choline—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.00108	0.00293	CcSEcCtD
Trisalicylate-choline—Headache—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00292	CcSEcCtD
Trisalicylate-choline—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00292	CcSEcCtD
Trisalicylate-choline—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00291	CcSEcCtD
Trisalicylate-choline—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00107	0.0029	CcSEcCtD
Trisalicylate-choline—Rash—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00288	CcSEcCtD
Trisalicylate-choline—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00287	CcSEcCtD
Trisalicylate-choline—Headache—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00286	CcSEcCtD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.00104	0.0168	CbGpPWpGaD
Trisalicylate-choline—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.0028	CcSEcCtD
Trisalicylate-choline—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00277	CcSEcCtD
Trisalicylate-choline—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00277	CcSEcCtD
Trisalicylate-choline—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00277	CcSEcCtD
Trisalicylate-choline—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00277	CcSEcCtD
Trisalicylate-choline—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00276	CcSEcCtD
Trisalicylate-choline—Nausea—Montelukast—chronic obstructive pulmonary disease	0.001	0.00271	CcSEcCtD
Trisalicylate-choline—PTGS2—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000969	0.0157	CbGpPWpGaD
Trisalicylate-choline—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000966	0.00261	CcSEcCtD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000952	0.0155	CbGpPWpGaD
Trisalicylate-choline—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.000949	0.0808	CbGeAlD
Trisalicylate-choline—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000949	0.00257	CcSEcCtD
Trisalicylate-choline—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000933	0.00252	CcSEcCtD
Trisalicylate-choline—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000918	0.00248	CcSEcCtD
Trisalicylate-choline—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.000907	0.0773	CbGeAlD
Trisalicylate-choline—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000902	0.00244	CcSEcCtD
Trisalicylate-choline—PTGS1—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000887	0.0144	CbGpPWpGaD
Trisalicylate-choline—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000885	0.0024	CcSEcCtD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.000881	0.0143	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000856	0.0139	CbGpPWpGaD
Trisalicylate-choline—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.000836	0.0711	CbGeAlD
Trisalicylate-choline—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00083	0.00225	CcSEcCtD
Trisalicylate-choline—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic obstructive pulmonary disease	0.000821	0.0133	CbGpPWpGaD
Trisalicylate-choline—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.000799	0.068	CbGeAlD
Trisalicylate-choline—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000798	0.00216	CcSEcCtD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.000784	0.0127	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000773	0.0125	CbGpPWpGaD
Trisalicylate-choline—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000769	0.00208	CcSEcCtD
Trisalicylate-choline—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000765	0.0651	CbGeAlD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	0.000758	0.0123	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000756	0.0123	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000753	0.0122	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000751	0.0122	CbGpPWpGaD
Trisalicylate-choline—PTGS2—bronchus—chronic obstructive pulmonary disease	0.000747	0.0636	CbGeAlD
Trisalicylate-choline—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000741	0.002	CcSEcCtD
Trisalicylate-choline—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000731	0.0622	CbGeAlD
Trisalicylate-choline—PTGS2—S1P1 pathway—VEGFA—chronic obstructive pulmonary disease	0.000716	0.0116	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000704	0.0114	CbGpPWpGaD
Trisalicylate-choline—PTGS1—trachea—chronic obstructive pulmonary disease	0.000702	0.0597	CbGeAlD
Trisalicylate-choline—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000678	0.00183	CcSEcCtD
Trisalicylate-choline—PTGS2—trachea—chronic obstructive pulmonary disease	0.000671	0.0571	CbGeAlD
Trisalicylate-choline—Shock—Prednisone—chronic obstructive pulmonary disease	0.000667	0.0018	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000655	0.00177	CcSEcCtD
Trisalicylate-choline—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000646	0.00175	CcSEcCtD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000623	0.0101	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000622	0.0101	CbGpPWpGaD
Trisalicylate-choline—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000617	0.00167	CcSEcCtD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000613	0.00996	CbGpPWpGaD
Trisalicylate-choline—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000597	0.00161	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000589	0.00159	CcSEcCtD
Trisalicylate-choline—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000588	0.00159	CcSEcCtD
Trisalicylate-choline—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000588	0.00159	CcSEcCtD
Trisalicylate-choline—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000584	0.00158	CcSEcCtD
Trisalicylate-choline—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00058	0.00157	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000558	0.00151	CcSEcCtD
Trisalicylate-choline—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000554	0.0015	CcSEcCtD
Trisalicylate-choline—PTGS1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000547	0.00888	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000541	0.00878	CbGpPWpGaD
Trisalicylate-choline—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000538	0.00146	CcSEcCtD
Trisalicylate-choline—PTGS1—lung—chronic obstructive pulmonary disease	0.000504	0.0429	CbGeAlD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000501	0.00813	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000495	0.00804	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.000491	0.00797	CbGpPWpGaD
Trisalicylate-choline—PTGS2—lung—chronic obstructive pulmonary disease	0.000482	0.041	CbGeAlD
Trisalicylate-choline—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000479	0.0013	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000464	0.00125	CcSEcCtD
Trisalicylate-choline—PTGS1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000455	0.00738	CbGpPWpGaD
Trisalicylate-choline—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000448	0.00121	CcSEcCtD
Trisalicylate-choline—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000431	0.00117	CcSEcCtD
Trisalicylate-choline—Rash—Prednisone—chronic obstructive pulmonary disease	0.000427	0.00116	CcSEcCtD
Trisalicylate-choline—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000427	0.00115	CcSEcCtD
Trisalicylate-choline—Headache—Prednisone—chronic obstructive pulmonary disease	0.000425	0.00115	CcSEcCtD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	0.000406	0.0066	CbGpPWpGaD
Trisalicylate-choline—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000403	0.00109	CcSEcCtD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000397	0.00646	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000384	0.00624	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000384	0.00624	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000384	0.00623	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000379	0.00616	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.000353	0.00573	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000348	0.00566	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	0.000332	0.00539	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00033	0.00536	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.000317	0.00516	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000312	0.00507	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	0.000308	0.005	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000305	0.00496	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000305	0.00496	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000305	0.00495	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.000302	0.00491	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	0.000301	0.00489	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	0.000287	0.00466	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	0.000283	0.00459	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000266	0.00432	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000248	0.00403	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000227	0.00368	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000211	0.00343	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	0.000204	0.00332	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	0.000196	0.00318	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000189	0.00308	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	0.000185	0.003	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.000183	0.00297	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.00018	0.00292	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000176	0.00286	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000175	0.00283	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	0.000171	0.00278	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000159	0.00259	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	0.000152	0.00247	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.00015	0.00244	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	0.000149	0.00243	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.000145	0.00236	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	0.000142	0.00231	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00014	0.00227	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000139	0.00225	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	0.000136	0.00221	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.00206	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000126	0.00205	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	0.000125	0.00204	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	0.000115	0.00186	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000113	0.00183	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000104	0.00168	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000102	0.00165	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.00164	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	9.68e-05	0.00157	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.35e-05	0.00152	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	9.24e-05	0.0015	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.62e-05	0.0014	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	8.53e-05	0.00139	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	8.44e-05	0.00137	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.77e-05	0.00126	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	7.45e-05	0.00121	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.42e-05	0.00121	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	7.34e-05	0.00119	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—KL—chronic obstructive pulmonary disease	6.93e-05	0.00113	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.84e-05	0.00111	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	6.7e-05	0.00109	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.48e-05	0.00105	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.39e-05	0.00104	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.17e-05	0.001	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.96e-05	0.000968	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.65e-05	0.000917	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	5.19e-05	0.000843	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.15e-05	0.000836	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.08e-05	0.000824	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.73e-05	0.000768	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.48e-05	0.000728	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	4.33e-05	0.000703	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	3.84e-05	0.000624	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.67e-05	0.000596	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	3.65e-05	0.000592	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	3.48e-05	0.000565	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	3.05e-05	0.000495	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.92e-05	0.000473	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	2.3e-05	0.000374	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	2.26e-05	0.000367	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	1.73e-05	0.000282	CbGpPWpGaD
